When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

The Future of Inflammatory Bowel Disease Therapy: Where Do We Go from Here?

(2013) William J. Sandborn   DIGESTIVE DISEASES

Deep Remission: A New Concept?

(2013) Jean-Frédéric Colombel et al.   DIGESTIVE DISEASES

The future of inflammatory bowel disease management: Combining progress in trial design with advances in targeted therapy

(2012) Simon Travis et al.   Journal of Crohns & Colitis

Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD

(2012) Pauliina Molander et al.   Journal of Crohns & Colitis

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

(2011) J. Panés et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis

(2011) Helen French et al.   DIGESTIVE DISEASES AND SCIENCES

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

(2011) Edouard Louis et al.   GASTROENTEROLOGY

Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort

(2010) A. W. G. Waugh et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

How Deep Is Remission in Perianal Crohn's Disease and Do Imaging Modalities Matter?

(2010) Guillaume Savoye et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

(2010) Stefan Schreiber et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy

(2010) H. Sokol et al.   GUT

Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study

(2010) Livia Biancone et al.   INFLAMMATORY BOWEL DISEASES

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial

(2009) Jean-Frédéric Colombel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

(2009) Filip Baert et al.   GASTROENTEROLOGY

Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel — EPACT II

(2009) Christian Felley et al.   Journal of Crohns & Colitis

Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel — EPACT II

(2009) Pascal Juillerat et al.   Journal of Crohns & Colitis

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel—EPACT II

(2009) Pierre Michetti et al.   Journal of Crohns & Colitis

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel—EPACT II

(2009) Christian Mottet et al.   Journal of Crohns & Colitis

Immunosuppression-associated lymphoma in IBD

(2009) Geert D'Haens et al.   LANCET

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease

(2008) U. HINDORF et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse

(2008) Xavier Treton et al.   Clinical Gastroenterology and Hepatology

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT